Now eligible for reimbursement from Medicare and Medicare Advantage! Learn More

Challenges of Treating Chronic Wounds

ActiGraftPro® system is the only wound care product that enables health care providers to produce—in real time—in vitro blood clots from your patient’s whole blood to support healing in chronic, non-healing wounds.

The Main Types of Chronic Wounds

Diabetic Ulcers

Pressure Injuries

Venous and Arterial
Ulcers

Mechanically or
Surgically-debrided Wounds

Transformative Autologous Wound Care Systems for Chronic, Non-healing Wounds.

ActiGraftPro® system

ActiGraftPro system is an autologous, point-of-care wound management system, that harnesses your patient’s own blood to support healing in chronic, non-healing wounds.

  • Creates an optimal, natural healing environment for wounds
  • Clinically proven with peer review published research and real-world case studies
  • Streamlines operational efficiency
  • Eco-friendly packaging
Learn more
5 min
Coagulation Time
72%
Complete wound closure rate
*Based on 12 weeks of treatment

Ready to reimagine your approach to wound healing?

Choose with Confidence

ActiGraftPro empowers you to choose with confidence.

Get Started

Eligible for reimbursement with Medicare and Medicare Advantage Plans

ActiGraftPro is described by the National Coverage Determination (NCD 270.3) as a blood-derived product for non-healing wounds and is eligible for reimbursement nationally from Medicare and Medicare Advantage.